Managed Care
Disease
Management

 

August 2013

Although Medicare and most health plans are reworking how they pay for health care, it will take years to eliminate the old way

Joseph Burns

A Harvard health economist and presidential campaign adviser says cost increases are on the right downward trajectory and will remain that way — as long as we keep pushing

With payers no longer the lone voice for real-world outcomes, who interprets value and how it is interpreted changes

Michael D. Dalzell

Along with greater precision, they could bring opportunities to coordinate the efforts of health plans and PBMs

Susan Worley

Minimally disruptive medicine, says the Mayo Clinic’s Victor Montori, is the kind of help today’s overwhelmed patients need

Peter Wehrwein



Departments
Medication Management

Biologics and high-cost medications are becoming mainstream, creating different challenges for insurers

Thomas Reinke
Evidence Review

A summary of ECRI Institute’s Emerging Technology Evidence Report

Legislation & Regulation

The FDA wants to significantly shorten the development time for new medications by cutting years out of the R&D process

John Carroll
Tomorrow's Medicine

In two studies, Lymphoseek outperformed previous agents in identifying nodes containing metastatic malignancies

Thomas Morrow, MD
Plan Watch

The Affordable Care Act stunts the growth of these institutions, but will quality of care and competition suffer as a result?